iXCells Biotechnologies and Rosebud Biosciences Partner to Advance Organoid-Based Models for Rare Diseases
Expansion of iXCells’ iPSCore platform with integration of 3D human organoid expertise will enable evaluation of drug toxicity and tissue-specific responses
January 27, 2026